Search results for: 'medgen and acquisition deaco and alliance of 2004'
- Did you mean
 - merger and acquisition deal and alliance of 2016
 
- Related search terms
 - acquisition texas and agreements in pharma
 - acquisition tech and agreements in pharma
 - acquisitions terms and agreements in pharma
 - acquisitions term and agreements in pharma
 - acquisitions test and agreements in pharma
 
- 
                
                    
                    Merger and Acquisition (M&A) Deals in Pharmaceuticals, Biotechnology and Diagnostics 2020-2025August 2025$3,995.00Global coverage | Deal financials | Contract documents | Deal trends | Leading M&A dealmakers | Comprehensive deal directory 2020 to 2025
Learn More - 
                
                    
                    Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2019-2025September 2025$3,995.00Option and Evaluation Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2019 to 2025
Learn More - 
                
                    
                    Distribution Deals in Pharmaceuticals and Biotechnology 2020 to 2025September 2025$3,995.00Distribution Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2020 to 2025
Learn More - 
                
                    
                    Royalty Rates in Pharmaceutical and Biotechnology Deals 2010 to 2025September 2025$4,995.00Essential Benchmark Data for Dealmakers | Global coverage | Updated to 2025 | 15+ years of royalty rates | Deal financials | Contract documents | Royalty rate trends
Learn More - 
                
                    
                    Global Specialty Pharmaceutical Partnering Terms and Agreements 2019-2025July 2025$3,995.00Global Specialty Pharmaceutical Partnering Terms and Agreements report provides a detailed understanding and analysis of how and why companies enter specialty pharmaceutical partnering deals.
Learn More - 
                
                    
                    Infectious Diseases Collaboration and Licensing Deals 2019-2025October 2025$3,995.00Infectious Diseases Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals | Comprehensive deal directory 2019 to 2025
Learn More - 
                
                    
                    Genitourinary Collaboration and Licensing Deals 2016-2025October 2025$3,995.00Genitourinary Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More - 
                
                    
                    Hematology Collaboration and Licensing Deals 2016-2025October 2025$3,995.00Hematology Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More - 
                
                    
                    Precision Medicine Collaboration and Licensing Deals 2019-2025May 2025$3,995.00Precision Medicine Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2019 to 2025
Learn More - 
                
                    
                    Infectious Vaccine Collaboration and Licensing Deals 2016-2025May 2025$3,995.00Infectious Vaccine Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More 
